The architecture of diagnostic research
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7336.539 (Published 02 March 2002) Cite this as: BMJ 2002;324:539Data supplement
Competing interests
David Sackett has been wined, dined, supported, transported, and paid to speak by countless pharmaceutical firms for over 40 years, beginning with two research fellowships and interest-free loans that allowed him to stay to finish medical school. Dozens of his randomised trials have been supported in part (but never in whole) by pharmaceutical firms, who have never received or analysed primary data and never had power of veto over any reports, presentations, or publications of the results. He has twice worked as a paid consultant to advise pharmaceutical firms whether their products caused lethal side effects; on both occasions he told them "yes." He has testified as an unpaid expert witness for a patient who sued a manufacturer of oral contraceptives after having a stroke and as a paid expert in preparing a class action suit against a manufacturer of prosthetic heart valves. He was paid by a pharmaceutical firm to develop "levels of evidence" for determining the causation of adverse drug reactions. His wife inherited and sold stock in a pharmaceutical company. While head of a division of medicine he enforced the banning of drug detail personnel from clinical teaching units (despite the threat of withdrawal of drug industry funding for residents' research projects). He received the Pharmaceutical Manufacturers' Association of Canada Medal of Honour (and cash) for "contributions to medical science in Canada" for the decade 1984-94. His most recent award (the 2001 Senior Investigator Award of the Canadian Society of Internal Medicine) was sponsored by Merck Frosst Canada.
Related articles
- Editor's Choice Published: 02 March 2002; BMJ 324 doi:10.1136/bmj.324.7336.0/g
- This Week In The BMJ Published: 02 March 2002; BMJ 324 doi:10.1136/bmj.324.7336.0/f
- Education And Debate Published: 24 March 2005; BMJ 330 doi:10.1136/bmj.330.7493.724
See more
- Rational, cost effective use of investigations in clinical practiceBMJ March 30, 2002, 324 (7340) 783-785; DOI: https://doi.org/10.1136/bmj.324.7340.783
- Clinical problem solving and diagnostic decision making: selective review of the cognitive literatureBMJ March 23, 2002, 324 (7339) 729-732; DOI: https://doi.org/10.1136/bmj.324.7339.729
- Designing studies to ensure that estimates of test accuracy are transferableBMJ March 16, 2002, 324 (7338) 669-671; DOI: https://doi.org/10.1136/bmj.324.7338.669
- Evaluation of diagnostic proceduresBMJ February 23, 2002, 324 (7335) 477-480; DOI: https://doi.org/10.1136/bmj.324.7335.477
Cited by...
- Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression in myelodysplastic neoplasms (MPO-MDS-Valid): protocol for a multicentre diagnostic accuracy study
- What tests and measures accurately diagnose persisting post-concussive symptoms in children, adolescents and adults following sport-related concussion? A systematic review
- Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study
- Response to: 'Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues by Ghajari and Sabour
- 'Youre the best liar in the world: a grounded theory study of rowing athletes experience of low back pain
- Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study
- What's happening in Innovations in Care Delivery
- Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care
- Predictive properties of risk assessment instruments following self-harm
- Early PREdiction of Severe Sepsis (ExPRES-Sepsis) study: protocol for an observational derivation study to discover potential leucocyte cell surface biomarkers
- The accuracy of diagnostic tests for GH deficiency in adults: a systematic review and meta-analysis
- Predicting the development of schizophrenia in high-risk populations: systematic review of the predictive validity of prodromal criteria
- Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule
- Accuracy of symptoms and signs for coronary heart disease assessed in primary care
- Screening for Suicide Ideation among Older Primary Care Patients
- SCAN minor stroke to rule out intracerebral haemorrhage
- Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review
- Diagnostic Utility of Cytokine Biomarkers in the Evaluation of Acute Knee Pain
- Overinterpretation of Clinical Applicability in Molecular Diagnostic Research
- Evaluating New Diagnostic Technologies: Perspectives in the UK and US
- 18F-FDG PET for Posttherapy Assessment of Hodgkin's Disease and Aggressive Non-Hodgkin's Lymphoma: A Systematic Review
- Indicators of Lumbar Zygapophyseal Joint Pain: Survey of an Expert Panel With the Delphi Technique
- Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM
- Are you reading what we are reading? The effect of who interprets medical images on estimates of diagnostic test accuracy in systematic reviews
- Signs and symptoms for diagnosis of serious infections in children: a prospective study in primary care
- Biomarker Discovery and Validation
- How does evidence on the diagnostic accuracy of the vertebral artery test influence teaching of the test in a professional physical therapist education program?
- Evidence-Based Guidelines in Laboratory Medicine: Principles and Methods
- Test Research versus Diagnostic Research
- Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: A randomized, controlled trial
- Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC
- Trends in Clinical Trials Reports in Common Cancers Between 1989 and 2000